Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Prospecting for molecular glues

Two recent studies identified CDK12 inhibitors that bind to CDK12–cyclin K complexes and act as molecular glues to stabilize an interaction with the ubiquitin ligase CUL4–DDB1, leading to cyclin K degradation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Mechanism of CDK12 inhibitor induced cyclin K degradation by CUL4–DDB1.


  1. Burslem, G. M. & Crews, C. M. Chem. Rev. 117, 11269–11301 (2017).

    Article  CAS  Google Scholar 

  2. Hanan, E. J. et al. J. Med. Chem. (2020).

  3. Słabicki, M. et al. Nature (2020).

  4. Mayor-Ruiz, C. et al. Nat. Chem. Biol. (2020).

  5. Uehara, T. et al. Nat. Chem. Biol. 13, 675–680 (2017).

    Article  CAS  Google Scholar 

  6. Han, T. et al. Science 356, eaal3755 (2017).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to J. Russell Lipford.

Ethics declarations

Competing interests

Both authors are employees and shareholders of Amgen.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

den Besten, W., Lipford, J.R. Prospecting for molecular glues. Nat Chem Biol 16, 1157–1158 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing